Low levels of pyrazinamide and ethambutol in children with tuberculosis and impact of age, nutritional status, and human immunodeficiency virus infection

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 2, 2006, Pages 407-413

  Graham, S M ^a,b,c   Bell, D J ^a,b   Nyirongo, S ^a   Hartkoorn, R ^b   Ward, S A ^b   Molyneux, E M ^a  

^a UNIVERSITY OF MALAWI   (Malawi)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^c MALAWI LIVERPOOL WELLCOME TRUST CLINICAL RESEARCH PROGRAMME   (Malawi)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ADOLESCENT; AGE; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CHILD; COMBINATION CHEMOTHERAPY; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; EXTRAPULMONARY TUBERCULOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALAWI; MALNUTRITION; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NUTRITIONAL STATUS; PRACTICE GUIDELINE; PRIORITY JOURNAL; TABLET; TUBERCULIN TEST;

ADOLESCENT; ADULT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; ETHAMBUTOL; HIV INFECTIONS; HUMANS; INFANT; MALNUTRITION; PYRAZINAMIDE; TUBERCULOSIS;

EID: 31944434382     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.50.2.407-413.2006     Document Type: Article

References (37)

1. Al Dossary, F. S., L. T. Ong, A. G. Correa, and J. R. Starke. 2002. Treatment of childhood tuberculosis with a six month directly observed regimen of only two weeks of daily therapy. Pediatr. Infect. Dis. J. 21:91-97.
2. Biddulph, J. 1990. Short course chemotherapy for childhood tuberculosis. Pediatr. Infect. Dis. J. 9:794-801.
3. Chintu, C., C. Luo, G. Bhat, M. Raviglione, H. DuPont, and A. Zumla. 1993. Cutaneous hypersensitivity reactions due to thiacetazone in the treatment of tuberculosis in Zambian children infected with HIV-I. Arch. Dis. Child. 68:665-668.
4. Chintu, C., V. Mudenda, S. Lucas, A. Nunn, K. Lishimpi, D. Maswahu, F. Kasolo, P. Mwaba, G. Bhat, H. Terunuma, and A. Zumla. 2002. Lung diseases at necropsy in African children dying from respiratory illnesses: a descriptive necropsy study. Lancet 360:985.
5. Espinal, M. A., A. L. Reingold, G. Perez, E. Camilo, S. Soto, E. Cruz, N. Matos, and G. Gonzalez. 1996. Human immunodeficiency virus infection in children with tuberculosis in Santo Domingo, Dominican Republic: prevalence, clinical findings, and response to antituberculosis treatment. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 13:155-159.
6. Gocmen, A., U. Ozcelic, N. Kiper, M. Toppare, S. Kaya, R. Cengizlier, and F. Cetinkaya. 1993. Short course intermittent chemotherapy in childhood tuberculosis. Infection 21:324-327.
7. Graham, S. M., H. M. Daley, A. Banerjee, F. M. Salaniponi, and A. D. Harries. 1998. Ethambutol in tuberculosis: time to reconsider? Arch. Dis. Child. 79:274-278.
8. Graham, S. M., R. P. Gie, H. S. Schaaf, J. B. Coulter, M. A. Espinal, and N. Beyers. 2004. Childhood tuberculosis: clinical research needs. Int. J. Tuberc. Lung Dis. 8:648-657.
9. Graham, S. M., and A. D. Harries. 1999. Childhood TB/HIV co-infection: correction, confusion and compliance. Int. J. Tuberc. Lung Dis. 3:1144.
10. Gurumurthy, P., G. Ramachandran, A. K. Hemanth Kumar, S. Rajasekaran, C. Padmapriyadarsini, S. Swaminathan, S. Bhagavathy, P. Venkatesan, L. Sekar, A. Mahilmaran, N. Ravichandran, and P. Paramesh. 2004. Decreased bioavailability of rifampin and other antituberculosis drugs in patients with advanced human immunodeficiency virus disease. Antimicrob. Agents Chemother. 48:4473-4475.
11. Gurumurthy, P., G. Ramachandran, A. K. Hemanth Kumar, S. Rajasekaran, C. Padmapriyadarsini, S. Swaminathan, P. Venkatesan, L. Sekar, S. Kumar, O. R. Krishnarajasekhar, and P. Paramesh. 2004. Malabsorption of rifampin and isoniazid in HIV-infected patients with and without tuberculosis. Clin. Infect. Dis. 38:280-283.
12. Harries, A. D., F. Gausi, and F. M. Salaniponi. 2004. Prescriptions and dosages of anti-tuberculosis drugs in the National Tuberculosis Control Programme of Malawi. Int. J. Tuberc. Lung Dis. 8:724-729.
13. Harries, A. D., N. J. Hargreaves, S. M. Graham, C. Mwansambo, P. Kazembe, R. L. Broadhead, D. Maher, and F. M. Salaniponi. 2002. Childhood tuberculosis in Malawi: nationwide case-finding and treatment outcomes. Int. J. Tuberc. Lung Dis. 6:424-431.
14. Hussels, H., U. Kroening, and K. Magdorf. 1973. Ethambutol and rifampicin serum levels in children: second report on the combined administration of ethambutol and rifampicin. Pneumonologie 149:31-38.
15. Jeena, P. M., P. Pillay, T. Pillay, and H. M. Coovadia. 2002. Impact of HIV-1 co-infection on presentation and hospital-related mortality in children with culture proven pulmonary tuberculosis in Durban, South Africa. Int. J. Tuberc. Lung Dis. 6:672-678.
16. Jindani, A., A. J. Nunn, and D. A. Enarson. 2004. Two 8-month regimens of chemotherapy for treatment of newly diagnosed pulmonary tuberculosis: international multicentre randomised trial. Lancet 364:1244-1251.
17. Kiwanuka, J., S. M. Graham, J. B. Coulter, J. S. Gondwe, N. Chilewani, H. Carty, and C. A. Hart. 2001. Diagnosis of pulmonary tuberculosis in children in an HIV-endemic area, Malawi. Ann. Trop. Paediatr. 21:5-14.
18. Madhi, S. A., R. E. Huebner, L. Doedens, T. Aduc, D. Wesley, and P. A. Cooper. 2000. HIV-1 co-infection in children hospitalised with tuberculosis in South Africa. Int. J. Tuberc. Lung Dis. 4:448-454.
19. Molyneux, E. M., A. L. Walsh, H. Forsyth, M. Tembo, J. Mwenechanya, K. Kayira, L. Bwanaisa, A. Njobvu, S. Rogerson, and G. Malenga. 2002. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet 360:211-218.
20. Mukadi, Y. D., S. Z. Wiktor, I. M. Coulibaly, D. Coulibaly, A. Mbengue, A. M. Folquet, A. Ackah, M. Sassan-Morokro, D. Bonnard, C. Maurice, C. Nolan, J. K. Kreiss, and A. E. Greenberg. 1997. Impact of HIV infection on the development, clinical presentation, and outcome of tuberculosis among children in Abidjan, Cote d'Ivoire. AIDS 11:1151-1158.
21. National Tuberculosis Control Programme, Malawi. 2002. Manual of the National Tuberculosis Control Programme of Malawi. Ministry of Health and Population, Lilongwe, Malawi.
22. Nunn, P., D. Kibuga, S. Gathua, R. Brindle, A. Imalingat, K. Wasunna, S, Lucas, C. Gilks, M. Omwega, J. Were, et al. 1991. Cutaneous hypersensitivity reactions due to thiacetazone in HIV-1 seropositive patients treated for tuberculosis. Lancet 337:627-630.
23. Palme, I. B., B. Gudetta, J. Bruchfeld, L. Muhe, and J. Giesecke. 2002. Impact of human immunodeficiency virus 1 infection on clinical presentation, treatment outcome and survival in a cohort of Ethiopian children with tuberculosis. Pediatr. Infect. Dis. J. 21:1053-1061.
24. Peloquin, C. A., A. E. Bulpitt, G. S. Jaresko, R. W. Jelliffe, J. M. Childs, and D. E. Nix. 1999. Pharmacokinetics of ethambutol under fasting conditions, with food, and with antacids. Antimicrob. Agents Chemother. 43:568-572.
25. Peloquin, C. A., R. Namdar, M. D. Singleton, and D. E. Nix. 1999. Pharmacokinetics of rifampin under fasting conditions, with food, and with antacids. Chest 115:12-18.
26. Peloquin, C. A., A. T. Nitta, W. J. Burman, K. F. Brudney, J. R. Miranda-Massari, M. E. McGuinness, S. E. Berning, and G. T. Gerena. 1996. Low antituberculosis drug concentrations in patients with AIDS. Ann. Pharmacother. 30:919-925.
27. Perlman, D. C., Y. Segal, S. Rosenkranz, P. M. Rainey, C. A. Peloquin, R. P. Remmel, K. Chirgwin, N. Salomon, and R. Hafner. 2004. The clinical pharmacokinetics of pyrazinamide in HIV-infected persons with tuberculosis. Clin. Infect. Dis. 38:556-564.
28. Salfinger, M., and L. B. Heifets. 1988. Determination of pyrazinamide MICs for Mycobacterium tuberculosis at different pHs by the radiometric method. Antimicrob. Agents Chemother. 32:1002-1004.
29. Schaaf, H. S., D. P. Parkin, H. I. Seifart, C. J. Werely, P. B. Hesseling, P. D. van Helden, J. S. Maritz, and P. R. Donald. 2005. Isoniazid pharmacokinetics in children treated for respiratory tuberculosis. Arch. Dis. Child. 90:614-618.
30. Seifart, H. I., P. R. Donald, J. N. De Villiers, D. P. Parkin, and P. P. Jaarsveld. 1995. Isoniazid elimination kinetics in children with protein-energy malnutrition treated for tuberculous meningitis with a four-component antimicrobial regimen. Ann. Trop. Paediatr. 15:249-254.
31. Seth, V., A. Beotra, A. Bagga, and S. Seth. 1992. Drug therapy in malnutrition. Indian Pediatr. 29:1341-1346.
32. Seth, V., A. Beotra, S. D. Seth, O. P. Semwal, S. Kabra, Y. Jain, and S. Mukhopadhya. 1993. Serum concentrations of rifampicin and isoniazid in tuberculosis. Indian Pediatr. 30:1091-1098.
33. Te Water Naude, J. M., P. R. Donald, G. D. Hussey, M. A. Kibel, A. Louw, D. R. Perkins, and H. S. Schaaf. 2000. Twice weekly vs. daily chemotherapy for childhood tuberculosis. Pediatr. Infect. Dis. J. 19:405-410.
34. Tsakalidis, D., P. Pratsidou, A. Hitoglou-Makedou, G. Tzouvelekis, and I. Sofroniadis. 1992. Intensive short course chemotherapy for treatment of Greek children with tuberculosis. Pediatr. Infect. Dis. J. 11:1036-1042.
35. World Health Organization. 2003. Treatment of tuberculosis: guidelines for national programmes. World Health Organization, Geneva, Switzerland.
36. Zhu, M., W. J. Burman, J. R. Starke, J. J. Stambaugh, P. Steiner, A. E. Bulpitt, D. Ashkin, B. Auclair, S. E. Berning, R. W. Jelliffe, G. S. Jaresko, and C. A. Peloquin. 2004. Pharmacokinetics of ethambutol in children and adults with tuberculosis. Int. J. Tuberc. Lung Dis. 8:1360-1367.
37. Zhu, M., J. R. Starke, W. J. Burman, P. Steiner, J. J. Stambaugh, D. Ashkin, A. E. Bulpitt, S. E. Berning, and C. A. Peloquin. 2002. Population pharmacokinetic modeling of pyrazinamide in children and adults with tuberculosis. Pharmacotherapy 22:686-695.